Intracoronary infusion of CD133+ endothelial progenitor cells improves heart function and quality of life in patients with chronic post-infarct heart insufficiency

This publication has 13 references indexed in Scilit:

• Molecular Epidemiology of Candidemia: Evidence of Clusters of Smoldering Nosocomial Infections
  Clinical Infectious Diseases, 2008
• Statistical Models and Patient Predictors of Readmission for Heart FailureA Systematic Review
  Archives of internal medicine (1960), 2008
• Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: Safety and efficacy studies
  The Journal of Thoracic and Cardiovascular Surgery, 2007
• Intramyocardial Implantation of CD133 + Stem Cells Improved Cardiac Function without Bypass Surgery
  The Heart Surgery Forum, 2007
• Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium
  Nature, 2004
• B-Type Natriuretic Peptides and Ejection Fraction for Prognosis After Myocardial Infarction
  Circulation, 2003
• Autologous bone-marrow stem-cell transplantation for myocardial regeneration
  The Lancet, 2003
• Therapeutic angiogenesis induced by local autologous bone marrow cell implantation
  The Annals of Thoracic Surgery, 2002
• ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure)
  Circulation, 2001
• Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function
  Nature Medicine, 2001